We are live on
!
Find out more
OCM
Orser Capital Management Portfolio holdings
AUM
$202M
1-Year Est. Return
32.65%
This Fund
S&P 500
This Quarter
Est. Return
+11.8%
1 Year Est. Return
+32.65%
3 Year Est. Return
+122.2%
5 Year Est. Return
+162.36%
10 Year Est. Return
–
AUM
$100M
AUM Growth
+$11.5M
(+13%)
Cap. Flow
+$2.24M
Cap. Flow
% of AUM
2.23%
Top 10 Holdings %
Top 10 Hldgs %
49.79%
Holding
54
New
3
Increased
15
Reduced
21
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Air Products & Chemicals
APD
|
+$1.19M |
| 2 |
Vanguard Morningstar Growth ETF
VUG
|
+$756K |
| 3 |
Vanguard Morningstar Value ETF
VTV
|
+$719K |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$716K |
| 5 |
Carpenter Technology
CRS
|
+$694K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$3.6M |
| 2 |
Boeing
BA
|
+$357K |
| 3 |
Procter & Gamble
PG
|
+$161K |
| 4 |
Microsoft
MSFT
|
+$87.8K |
| 5 |
Waste Management
WM
|
+$81K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.4% |
| 2 | Healthcare | 13.04% |
| 3 | Consumer Staples | 8.45% |
| 4 | Industrials | 8.21% |
| 5 | Consumer Discretionary | 8.01% |
Similar funds
PRI
NIMC
MPM
ACM
NME
FB
MFG
LWMI
Orser Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Orser Capital Management held 54 positions worth $100M, up 13% from $88.7M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Orser Capital Management's Q2 2023 filing shows 3 new, 15 increased, 21 reduced and 2 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 1,855 shares worth $756K. The largest sale was Edwards Lifesciences, an estimated $3.6M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Staples.
- Orser Capital Management's largest Q2 2023 buy was Vanguard S&P 500 ETF: 1,855 shares worth $756K.
- Orser Capital Management added most to Air Products & Chemicals in Q2 2023, an estimated $1.19M increase.
- Orser Capital Management's biggest Q2 2023 reduction was Procter & Gamble, cutting an estimated $161K.
- Orser Capital Management fully exited Edwards Lifesciences in Q2 2023, selling an estimated $3.6M.
- Orser Capital Management's ten largest holdings make up 50% of its $100M portfolio in Q2 2023.
- Orser Capital Management opened 3 new positions and closed 2 in Q2 2023.
- Orser Capital Management's portfolio value rose 13% quarter-over-quarter to $100M.
Based on Orser Capital Management's 13F filing for Q2 2023, filed 11 Jul 2023.